Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,384,104 papers from all fields of science
Search
Sign In
Create Free Account
PIK3IP1 gene
Known as:
MGC17330
, HGFL
, phosphoinositide-3-kinase interacting protein 1
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Abstract P5-13-01: Transcript analysis of PI3K and immune-related genes and gene signatures in the pre- and post-treatment samples from the window of opportunity study of anastrozole and anastrozole…
P. Schmid
,
S. Pinder
,
+19 authors
S. Gendreau
2016
Corpus ID: 76842076
Background: The OPPORTUNE Study randomized postmenopausal patients (pts) to receive 2-week preoperative treatment with…
Expand
2012
2012
Cancer Therapy : Preclinical AT 13148 Is a Novel , Oral Multi-AGC Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity
T. Yap
,
M. Walton
,
+19 authors
M. Garrett
2012
Corpus ID: 35748451
Purpose:Deregulated phosphatidylinositol 3-kinase pathway signaling through AGC kinases including AKT, p70S6 kinase, PKA, SGK and…
Expand
2008
2008
Role of PIK 3 IP 1 , a negative PI 3 K regulator , in hepatic tumorigenesis and metabolism
H. Xin
,
Xin He
,
D. Stolz
,
S. Strom
,
S. Monga
2008
Corpus ID: 47854371
2008
2008
Role of PIK3IP1, a negative PI3K regulator, in hepatic tumorigenesis and metabolism
Xin He
2008
Corpus ID: 86833719
Phosphatidylinositol-3-kinase (PI3K) is a well-known regulator of cell division, motility, metabolism and survival in most cell…
Expand
2007
2007
PIK3IP1, a novel negative regulator of PI3K, inhibits hepatocyte DNA synthesis, migration and survival in vitro
Xin He
,
Zhenqi Zhu
,
Carla J Johnson
,
Amanda E Eaker
,
J. Stoops
,
M. Defrances
2007
Corpus ID: 83430100
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required